Panel Discussion |Are AI-based Technologies evolving Cardiovascular Patient Engagement?

Monday, March 9, 2026

9:42 AM - 10:00 AM EST

Location: Cabinet

Moderator(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Richard E. Galgon, MD, MS

Principal Consultant
CardioMed Device Consultants, LLC
Waunakee, Wisconsin, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure(s): ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Semih Oktay, PhD

President
Cardiomed Device Consultants
Annapolis, Maryland, United States

Disclosure(s): Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)
Allen J. Taylor, MD

Chairman of Cardiology
MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Heartflow Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Richard E. Galgon, MD, MS: No financial relationships to disclose

Rafael Beyar, MD, DSc, MPH: ALIVE VC: Managing General Partner (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Director and stock owner (Ongoing); Cuspa medical: Advisor (Ongoing), Stock Options [in privately held companies] (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Semih Oktay, PhD: Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)

Allen J. Taylor, MD: Heartflow Inc.: Consulting Fees (e.g., advisory boards) (Ongoing)

Roseann M. White, MA: Cardiovascular Research Foundation: Consulting Fees (e.g., advisory boards) (Ongoing); Natera: Stock-publicly held company (excluding mutual/index funds) (Ongoing)